Authors:
CASCINU S
DELFERRO E
BARBANTI I
LIGI M
FEDELI A
CATALANO G
Citation: S. Cascinu et al., TUMOR-MARKERS IN THE DIAGNOSIS OF MALIGNANT SEROUS EFFUSIONS, American journal of clinical oncology, 20(3), 1997, pp. 247-250
Authors:
CASCINU S
ALESSANDRONI P
ROSSI D
DELFERRO E
FEDELI A
CASADEI V
CATALANO G
Citation: S. Cascinu et al., MULTIMODAL BIOCHEMICAL MODULATION OF 5-FLUOROURACIL BY LEUCOVORIN, METHOTREXATE, AND INTERFERON-ALPHA IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 385-386
Authors:
TUMMARELLO D
GRAZIANO F
ISIDORI P
SANTO A
CETTO G
FEDELI A
ROSSI G
CELLERINO R
Citation: D. Tummarello et al., CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY, Cancer, 77(11), 1996, pp. 2251-2257
Authors:
CASCINU S
DELFERRO E
GRIANTI C
FEDELI A
CATALANO G
Citation: S. Cascinu et al., ORAL ESCALATING DOSE OF CYCLOSPORINE-A COMBINED WITH 4-EPIDOXORUBICININ ADVANCED COLORECTAL-CANCER - A PHASE-I STUDY, Oncology Reports, 2(6), 1995, pp. 1033-1035
Authors:
CASCINU S
LATINI L
FEDELI A
GIORDANI P
ANTOGNOLI S
CATALANO G
CELLERINO R
Citation: S. Cascinu et al., THE CLINICAL IMPACT OF FEM REGIMEN (5-FLUOROURACIL, 4-EPIDOXORUBICIN AND MITOMYCIN-C) IN ADVANCED GASTRIC-CANCER PATIENTS, Anticancer research, 15(6B), 1995, pp. 2781-2783
Authors:
CASCINU S
DELFERRO E
FEDELI A
LIGI M
ALESSANDRONI P
CATALANO G
Citation: S. Cascinu et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN ELDERLY CANCER-PATIENTSWITH CISPLATIN-ASSOCIATED ANEMIA, Oncology, 52(5), 1995, pp. 422-426
Authors:
CASCINU S
FEDELI A
DELFERRO E
FEDELI SL
CATALANO G
Citation: S. Cascinu et al., CARBOPLATIN ASSOCIATED ANEMIA TREATED WITH SUBCUTANEOUS ERYTHROPOIETIN - A PILOT-STUDY, Oncology Reports, 1(1), 1994, pp. 169-172
Citation: S. Cascinu et al., ORAL COOLING (CRYOTHERAPY), AN EFFECTIVE TREATMENT FOR THE PREVENTIONOF 5-FLUOROURACIL-INDUCED STOMATITIS, European journal of cancer. Part B, Oral oncology, 30B(4), 1994, pp. 234-236
Authors:
CASCINU S
FEDELI A
DELFERRO E
FEDELI SL
CATALANO G
Citation: S. Cascinu et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN CISPLATIN-ASSOCIATED ANEMIA - A RANDOMIZED, DOUBLE-BLIND TRIAL WITH PLACEBO, Journal of clinical oncology, 12(5), 1994, pp. 1058-1062
Citation: S. Cascinu et al., ETOPOSIDE, LEUCOVORIN, 5-FLUOROURACIL AND INTERFERON-ALPHA-2B IN ELDERLY GASTRIC-CANCER PATIENTS - A PILOT-STUDY, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 72-74
Citation: S. Cascinu et al., CONTROL OF CHEMOTHERAPY-INDUCED DIARRHEA WITH OCTREOTIDE - A RANDOMIZED TRIAL WITH PLACEBO IN PATIENTS RECEIVING CISPLATIN, Oncology, 51(1), 1994, pp. 70-73
Citation: S. Cascinu et al., CISPLATIN, 5-FLUOROURACIL AND INTERFERON-ALPHA-2B FOR RECURRENT OR METASTATIC HEAD AND NECK-CANCER, British Journal of Cancer, 69(2), 1994, pp. 392-393
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR, International journal of oncology, 3(3), 1993, pp. 535-538
Authors:
CASCINU S
ISIDORI PP
FEDELI A
FEDELI SL
ROSSI A
UGOLINI M
CACCIANI GC
CATALANO G
Citation: S. Cascinu et al., A PHASE-1 STUDY OF CARBOPLATIN AND ALPHA-2 INTERFERON IN PATIENTS WITH MALIGNANT PLEURAL EFFUSIONS, The Cancer journal, 6(6), 1993, pp. 330-333
Citation: S. Cascinu et al., CISPLATIN TREATMENT IN CANCER-PATIENTS WITH HYPERBILIRUBINEMIA DUE TOSECONDARY LIVER INVOLVEMENT, The Cancer journal, 6(3), 1993, pp. 151-153
Authors:
CASCINU S
DELFERRO E
FEDELI A
GRIANTI C
FOGLIETTI G
OLIVIERI Q
ACETOSO M
BARTOLUCCI M
SABA V
LUNGAROTTI F
CATALANO G
Citation: S. Cascinu et al., CYTOKINETIC EFFECTS OF INTERFERON IN COLORECTAL-CANCER TUMORS - IMPLICATIONS IN THE DESIGN OF THE INTERFERON 5-FLUOROURACIL COMBINATIONS/, Cancer research, 53(22), 1993, pp. 5429-5432
Citation: S. Cascinu et al., SALVAGE CHEMOTHERAPY IN COLORECTAL-CANCER PATIENTS WITH GOOD PERFORMANCE STATUS AND YOUNG AGE AFTER FAILURE OF 5-FLUOROURACIL LEUCOVORIN COMBINATION, Journal of chemotherapy, 4(1), 1992, pp. 46-49